ws 79089b has been researched along with Cardiac Failure in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, M; Kinoshita, M; Matsumoto, T; Ohnishi, M; Tsutamoto, T; Wada, A; Wang, X; Yamamoto, T | 1 |
Emoto, N | 1 |
Fukai, D; Kinoshita, M; Maeda, Y; Ohnishi, M; Sawaki, M; Tsutamoto, T; Wada, A | 1 |
Ergul, A; Grubbs, AL; Spinale, FG; Zhang, Y | 1 |
Fujii, M; Kinoshita, M; Kurokawa, K; Matsumoto, T; Ohnishi, M; Sawaki, M; Tsutamoto, T; Wada, A; Wang, X; Yamada, H; Yamamoto, T | 1 |
1 review(s) available for ws 79089b and Cardiac Failure
Article | Year |
---|---|
[Physiological and pathophysiological roles of the endothelin converting enzymes].
Topics: Animals; Aspartic Acid Endopeptidases; Benzazepines; Benzofurans; Drug Design; Endothelin-Converting Enzymes; Glycopeptides; Heart Failure; Humans; Hypertension; Metalloendopeptidases; Mice; Mice, Knockout; Myocardial Infarction; Organophosphonates; Phenylalanine; Tetracyclines; Tetrazoles | 2004 |
4 other study(ies) available for ws 79089b and Cardiac Failure
Article | Year |
---|---|
Chronic effects of an endothelin-converting enzyme inhibitor on cardiorenal and hormonal function in heart failure.
Topics: Aldosterone; Animals; Aspartic Acid Endopeptidases; Atrial Natriuretic Factor; Cardiac Output; Cardiac Pacing, Artificial; Dogs; Endothelin-Converting Enzymes; Enzyme Inhibitors; Glomerular Filtration Rate; Heart Failure; Metalloendopeptidases; Models, Animal; Pulmonary Wedge Pressure; Renal Circulation; Tetracyclines | 2002 |
Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Blood Pressure; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Female; Heart; Heart Failure; Hemodynamics; Indoles; Kidney; Male; Neuropeptides; Pulmonary Wedge Pressure; Receptor, Endothelin A; Tetracyclines; Time Factors; Vascular Resistance | 1999 |
Selective upregulation of endothelin converting enzyme-1a in the human failing heart.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspartic Acid Endopeptidases; Cardiomyopathy, Dilated; Case-Control Studies; Endothelin-Converting Enzymes; Gene Expression Regulation; Heart Failure; Heart Transplantation; Heart Ventricles; Humans; Metalloendopeptidases; Phenylalanine; Reverse Transcriptase Polymerase Chain Reaction; Tetracyclines; Thiophenes; Up-Regulation | 2000 |
Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor.
Topics: Animals; Aspartic Acid Endopeptidases; Dogs; Endothelin-1; Endothelin-Converting Enzymes; Endothelium, Vascular; Enzyme Inhibitors; Female; Heart Failure; Hemodynamics; Immunohistochemistry; Male; Metalloendopeptidases; Tetracyclines | 2001 |